Crossmark

The molecular characteristics could supplement the staging system of pT2/T3N0M0 esophageal squamous cell carcinoma: a translational study based on a cohort with over 20 years of follow-up

Crossref DOI link: https://doi.org/10.1186/s12935-024-03286-5

Published Online: 2024-03-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jiang, Wen-Mei

Tian, Jia-Yuan

Guo, Yi-Han

Qiu, Li-Hong

Luo, Xing-Yu

Huang, Yang-Yu

Long, Hao

Zhang, Lan-Jun

Lin, Peng

Xu, Xin-Xin

Wu, Lei-Lei

Ma, Guo-Wei
License Information

Text and Data Mining valid from 2024-03-30

Version of Record valid from 2024-03-30
More Information

Article History

Received: 26 October 2023

Accepted: 29 February 2024

First Online: 30 March 2024

Declarations

:

: The Clinical Research Ethic Committee of Sun Yat-sen University Cancer Center approved this study (No. YB2016-072), and the human data was in accordance with the Declaration of Helsinki in the manuscript, with the need for informed consent waived for this retrospective study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below